These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 38341509)
1. Unraveling the impact of cancer-associated fibroblasts on hypovascular pancreatic neuroendocrine tumors. Lai TY; Chiang TC; Lee CY; Kuo TC; Wu CH; Chen YI; Hu CM; Maskey M; Tang SC; Jeng YM; Tien YW; Lee EYP; Lee WH Br J Cancer; 2024 Apr; 130(7):1096-1108. PubMed ID: 38341509 [TBL] [Abstract][Full Text] [Related]
2. Alpha-smooth muscle actin-positive cancer-associated fibroblasts secreting osteopontin promote growth of luminal breast cancer. Muchlińska A; Nagel A; Popęda M; Szade J; Niemira M; Zieliński J; Skokowski J; Bednarz-Knoll N; Żaczek AJ Cell Mol Biol Lett; 2022 Jun; 27(1):45. PubMed ID: 35690734 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-8 produced from cancer-associated fibroblasts suppresses proliferation of the OCUCh-LM1 cancer cell line. Tanaka R; Kimura K; Eguchi S; Ohira G; Tanaka S; Amano R; Tanaka H; Yashiro M; Ohira M; Kubo S BMC Cancer; 2022 Jul; 22(1):748. PubMed ID: 35804329 [TBL] [Abstract][Full Text] [Related]
4. Improving fine needle aspiration to predict the tumor biological aggressiveness in pancreatic neuroendocrine tumors using Ki-67 proliferation index, phosphorylated histone H3 (PHH3), and BCL-2. Zhao CL; Dabiri B; Hanna I; Lee L; Xiaofei Z; Hossein-Zadeh Z; Cao W; Allendorf J; Rodriguez AP; Weng K; Turunbedu S; Boyd A; Gupta M Ann Diagn Pathol; 2023 Aug; 65():152149. PubMed ID: 37119647 [TBL] [Abstract][Full Text] [Related]
5. Periostin- and podoplanin-positive cancer-associated fibroblast subtypes cooperate to shape the inflamed tumor microenvironment in aggressive pancreatic adenocarcinoma. Neuzillet C; Nicolle R; Raffenne J; Tijeras-Raballand A; Brunel A; Astorgues-Xerri L; Vacher S; Arbateraz F; Fanjul M; Hilmi M; Samain R; Klein C; Perraud A; Rebours V; Mathonnet M; Bièche I; Kocher H; Cros J; Bousquet C J Pathol; 2022 Dec; 258(4):408-425. PubMed ID: 36102377 [TBL] [Abstract][Full Text] [Related]
6. The stromal microenvironment endows pancreatic neuroendocrine tumors with spatially specific invasive and metastatic phenotypes. Ye Z; Li Q; Hu Y; Hu H; Xu J; Guo M; Zhang W; Lou X; Wang Y; Gao H; Jing D; Fan G; Qin Y; Zhang Y; Chen X; Chen J; Xu X; Yu X; Liu M; Ji S Cancer Lett; 2024 Apr; 588():216769. PubMed ID: 38438098 [TBL] [Abstract][Full Text] [Related]
7. mTOR kinase inhibition reduces tissue factor expression and growth of pancreatic neuroendocrine tumors. Lewis CS; Elnakat Thomas H; Orr-Asman MA; Green LC; Boody RE; Matiash K; Karve A; Hisada YM; Davis HW; Qi X; Mercer CA; Lucas FV; Aronow BJ; Mackman N; Versteeg HH; Bogdanov VY J Thromb Haemost; 2019 Jan; 17(1):169-182. PubMed ID: 30472780 [TBL] [Abstract][Full Text] [Related]
8. Pancreatic neuroendocrine tumour (PNET): Staging accuracy of MDCT and its diagnostic performance for the differentiation of PNET with uncommon CT findings from pancreatic adenocarcinoma. Kim JH; Eun HW; Kim YJ; Lee JM; Han JK; Choi BI Eur Radiol; 2016 May; 26(5):1338-47. PubMed ID: 26253257 [TBL] [Abstract][Full Text] [Related]
10. Cancer-associated fibroblasts secrete hypoxia-induced serglycin to promote head and neck squamous cell carcinoma tumor cell growth in vitro and in vivo by activating the Wnt/β-catenin pathway. Xie J; Qi X; Wang Y; Yin X; Xu W; Han S; Cai Y; Han W Cell Oncol (Dordr); 2021 Jun; 44(3):661-671. PubMed ID: 33651283 [TBL] [Abstract][Full Text] [Related]
11. circNOX4 activates an inflammatory fibroblast niche to promote tumor growth and metastasis in NSCLC via FAP/IL-6 axis. Zhao Y; Jia Y; Wang J; Chen X; Han J; Zhen S; Yin S; Lv W; Yu F; Wang J; Xu F; Zhao X; Liu L Mol Cancer; 2024 Mar; 23(1):47. PubMed ID: 38459511 [TBL] [Abstract][Full Text] [Related]
12. Chemotherapy-Induced Inflammatory Gene Signature and Protumorigenic Phenotype in Pancreatic CAFs via Stress-Associated MAPK. Toste PA; Nguyen AH; Kadera BE; Duong M; Wu N; Gawlas I; Tran LM; Bikhchandani M; Li L; Patel SG; Dawson DW; Donahue TR Mol Cancer Res; 2016 May; 14(5):437-47. PubMed ID: 26979711 [TBL] [Abstract][Full Text] [Related]
13. GPR68, a proton-sensing GPCR, mediates interaction of cancer-associated fibroblasts and cancer cells. Wiley SZ; Sriram K; Liang W; Chang SE; French R; McCann T; Sicklick J; Nishihara H; Lowy AM; Insel PA FASEB J; 2018 Mar; 32(3):1170-1183. PubMed ID: 29092903 [TBL] [Abstract][Full Text] [Related]
14. Identification of Functional Heterogeneity of Carcinoma-Associated Fibroblasts with Distinct IL6-Mediated Therapy Resistance in Pancreatic Cancer. McAndrews KM; Chen Y; Darpolor JK; Zheng X; Yang S; Carstens JL; Li B; Wang H; Miyake T; Correa de Sampaio P; Kirtley ML; Natale M; Wu CC; Sugimoto H; LeBleu VS; Kalluri R Cancer Discov; 2022 Jun; 12(6):1580-1597. PubMed ID: 35348629 [TBL] [Abstract][Full Text] [Related]
15. Bruceine D suppresses CAF-promoted TNBC metastasis under TNF-α stimulation by inhibiting Notch1-Jagged1/NF-κB(p65) signaling. Chen H; Han X; Zhang Y; Wang K; Liu D; Hu Z; Wang J Phytomedicine; 2024 Jan; 123():154928. PubMed ID: 38043386 [TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of FGFR2 Qiu H; Zhang X; Qi J; Zhang J; Tong Y; Li L; Fu L; Qin YR; Guan X; Zhang L J Exp Clin Cancer Res; 2022 Aug; 41(1):240. PubMed ID: 35941662 [TBL] [Abstract][Full Text] [Related]
18. Vascular mimicry formation is promoted by paracrine TGF-β and SDF1 of cancer-associated fibroblasts and inhibited by miR-101 in hepatocellular carcinoma. Yang J; Lu Y; Lin YY; Zheng ZY; Fang JH; He S; Zhuang SM Cancer Lett; 2016 Dec; 383(1):18-27. PubMed ID: 27693460 [TBL] [Abstract][Full Text] [Related]
19. Paracrine signalling of AGR2 stimulates RhoA function in fibroblasts and modulates cell elongation and migration. Mangukiya HB; Negi H; Merugu SB; Sehar Q; Mashausi DS; Yunus FU; Wu Z; Li D Cell Adh Migr; 2019 Dec; 13(1):332-344. PubMed ID: 31710263 [TBL] [Abstract][Full Text] [Related]
20. BAG3 induces α-SMA expression in human fibroblasts and its over-expression correlates with poorer survival in fibrotic cancer patients. De Marco M; Del Papa N; Reppucci F; Iorio V; Basile A; Falco A; Iaccarino R; Brongo S; De Caro F; Capunzo M; Turco MC; Rosati A; Marzullo L J Cell Biochem; 2022 Jan; 123(1):91-101. PubMed ID: 34741483 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]